Press Releases

Genenta Imaging Partnership with IAG Optimizes Phase I/IIa Study of Temferon™ in Glioblastoma

Posted on February 2, 2021February 2, 2021 by genenta
Press Releases

Genenta to take part in gene therapy panel and two virtual investor events in January 2021

Posted on January 5, 2021January 7, 2021 by genenta
Press Releases

Genenta to appoint Stephen Squinto, experienced biotech executive and investor, as Chairman

Posted on November 23, 2020 by genenta
Press Releases

Genenta’s TemferonTM: Evidence of Controlled and Targeted Interferon Expression in Preliminary Phase I/II Clinical Data in Glioblastoma Multiforme

Posted on November 16, 2020 by genenta
Press Releases

Genenta to present preliminary Phase I/II clinical data on TemferonTM in glioblastoma multiforme at Chardan’s 4th Annual Genetic Medicines Conference

Posted on September 30, 2020October 15, 2020 by genenta
Press Releases

Genenta presents company’s pipeline and the preliminary clinical data from Phase I/II in patients affected with glioblastoma multiforme at the Advanced Therapies Congress & Expo 2020

Posted on September 8, 2020October 15, 2020 by genenta
Press Releases

Genenta to present at the LifeSci Partners Summer Symposium

Posted on July 30, 2020November 30, 2020 by genenta
Press Releases

Genenta presents the company overview at the Access China Forum 2020

Posted on July 30, 2020October 15, 2020 by genenta
Press Releases

Genenta presents at ASGCT preliminary pre-clinical and clinical data from TemferonTM Phase 1/2 study in patients with glioblastoma multiforme

Posted on May 15, 2020October 15, 2020 by genenta
Press Releases

Genenta presents preliminary pre-clinical and clinical data from a Phase 1/2 study in patients with glioblastoma multiforme at American Society of Gene & Cell Therapy

Posted on May 4, 2020October 15, 2020 by genenta
Press Releases
  • 1
  • 2
  • 3
  • »

CONTACT

Via Olgettina 58
20132 Milano
Italy

    LaunchLabs - Alexandria Center
14th Floor
Suite 1456E
430 East 29th Street
New York NY 10016
United States

Email Inquiry

I read the information pursuant to art. 13 of EU Regulation no. 2016/679 concerning the protection of personal data
Please confirm that you have read the information on the processing of personal data
© 2015 genenta science. All Rights Reserved

Terms & Conditions - Cookie Policy